NO20005732L - Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer - Google Patents

Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer

Info

Publication number
NO20005732L
NO20005732L NO20005732A NO20005732A NO20005732L NO 20005732 L NO20005732 L NO 20005732L NO 20005732 A NO20005732 A NO 20005732A NO 20005732 A NO20005732 A NO 20005732A NO 20005732 L NO20005732 L NO 20005732L
Authority
NO
Norway
Prior art keywords
phenylethylamines
phenylsulfonamide
useful
dopamine receptors
alkyl
Prior art date
Application number
NO20005732A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005732D0 (no
Inventor
Arthur Glenn Romero
Jeffrey A Leiby
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20005732D0 publication Critical patent/NO20005732D0/no
Publication of NO20005732L publication Critical patent/NO20005732L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005732A 1998-05-14 2000-11-13 Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer NO20005732L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8549398P 1998-05-14 1998-05-14
PCT/US1999/007023 WO1999058499A1 (en) 1998-05-14 1999-05-07 Phenylsulfonamide-phenylethylamines useful as dopamine receptors

Publications (2)

Publication Number Publication Date
NO20005732D0 NO20005732D0 (no) 2000-11-13
NO20005732L true NO20005732L (no) 2000-11-13

Family

ID=22191975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005732A NO20005732L (no) 1998-05-14 2000-11-13 Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer

Country Status (25)

Country Link
US (1) US6103766A (zh)
EP (1) EP1077935B1 (zh)
JP (1) JP2002514623A (zh)
KR (1) KR20010043546A (zh)
CN (1) CN1152857C (zh)
AT (1) ATE253045T1 (zh)
AU (1) AU752543B2 (zh)
BR (1) BR9910405A (zh)
CA (1) CA2327345A1 (zh)
DE (1) DE69912419T2 (zh)
DK (1) DK1077935T3 (zh)
EA (1) EA002918B1 (zh)
ES (1) ES2211078T3 (zh)
HK (1) HK1036049A1 (zh)
HU (1) HUP0101746A3 (zh)
IL (1) IL139263A0 (zh)
NO (1) NO20005732L (zh)
NZ (1) NZ508152A (zh)
PL (1) PL343891A1 (zh)
PT (1) PT1077935E (zh)
SK (1) SK16242000A3 (zh)
TR (1) TR200003325T2 (zh)
TW (1) TW450954B (zh)
WO (1) WO1999058499A1 (zh)
ZA (1) ZA200005921B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT971878E (pt) * 1997-02-27 2008-07-08 Takeda Pharmaceutical Compostos de amina, sua produção e utilização como inibidores da produção de amilóide beta
US6849635B2 (en) * 2001-05-07 2005-02-01 Smithkline Beecham Corporation Sulfonamides
EP1385495A4 (en) * 2001-05-07 2005-12-21 Smithkline Beecham Corp SULPHONAMIDES
JP4754570B2 (ja) 2004-10-14 2011-08-24 アボット ゲーエムベーハー ウント カンパニー カーゲー ドーパミンｄ３受容体の調節に応答する障害の治療に好適なアザビシクロヘプチル化合物
AU2005293698B2 (en) 2004-10-14 2011-12-15 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
EP2371814A1 (en) 2004-10-14 2011-10-05 Abbott GmbH & Co. KG Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
PE20080057A1 (es) * 2006-04-14 2008-03-10 Abbott Gmbh & Co Kg Compuestos de ariloxietilamina como agentes moduladores del receptor de dopamina d3
US8383641B2 (en) 2006-04-14 2013-02-26 Abbott Gmbh & Co. Kg Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
MX2008013206A (es) 2006-04-19 2008-10-22 Abbott Gmbh & Co Kg Compuestos heterociclicos adecuados para el tratamiento de trastornos que responden a modulacion del receptor de serotonina 5ht6.
JP2009534354A (ja) 2006-04-19 2009-09-24 アボット ゲーエムベーハー ウント カンパニー カーゲー セロトニン５ｈｔ６受容体の調節に応答する障害を治療するために好適な複素環アリールスルホン類
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9402197D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
CA2205998C (en) * 1994-11-23 2002-07-16 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
PL329803A1 (en) * 1996-05-11 1999-04-12 Smithkline Beecham Plc Derivatives of tetrahydroisoquinoline as modulators od dopamine d receptors
DE69734215T2 (de) * 1996-07-22 2006-06-29 Novo Nordisk A/S Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
JPH1180156A (ja) * 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd １−（置換アリール）アルキル−１ｈ−イミダゾピリジン−４−アミン誘導体

Also Published As

Publication number Publication date
TW450954B (en) 2001-08-21
US6103766A (en) 2000-08-15
EP1077935B1 (en) 2003-10-29
KR20010043546A (ko) 2001-05-25
CN1152857C (zh) 2004-06-09
HK1036049A1 (en) 2001-12-21
SK16242000A3 (sk) 2001-06-11
HUP0101746A3 (en) 2002-10-28
WO1999058499A1 (en) 1999-11-18
NO20005732D0 (no) 2000-11-13
PT1077935E (pt) 2004-03-31
CN1297431A (zh) 2001-05-30
HUP0101746A2 (hu) 2002-03-28
AU752543B2 (en) 2002-09-19
AU3741899A (en) 1999-11-29
ZA200005921B (en) 2001-11-14
EA002918B1 (ru) 2002-10-31
BR9910405A (pt) 2001-01-09
IL139263A0 (en) 2001-11-25
ATE253045T1 (de) 2003-11-15
EP1077935A1 (en) 2001-02-28
CA2327345A1 (en) 1999-11-18
DE69912419D1 (de) 2003-12-04
EA200001184A1 (ru) 2001-04-23
NZ508152A (en) 2003-03-28
JP2002514623A (ja) 2002-05-21
PL343891A1 (en) 2001-09-10
TR200003325T2 (tr) 2001-04-20
DE69912419T2 (de) 2004-07-22
DK1077935T3 (da) 2004-02-16
ES2211078T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
NO20005732D0 (no) Fenylsulfonamidfenyletylaminer anvendbare som dopaminreseptorer
DK0923542T3 (da) Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander
ES2031513T3 (es) Quinazolindionas y piridopirimidinadionas.
FI973176A0 (fi) Selektiivisinä dopamiini-D3-ligandeina toimivia 2-aminoindaaneja
EA200200291A1 (ru) Производные биариловых эфиров, полезные в качестве ингибиторов обратного захвата моноамина
PE20031011A1 (es) Derivados de dihidrobenzodiazepin-2-ona-iii
YU56301A (sh) Inhibitori resorpcije monoamina za tretiranje poremećaja cns
PE20000467A1 (es) Derivado de indol util como inhibidor de serotonina
PE20020346A1 (es) Derivados de fenoxibencilamina como ssri
PE20000127A1 (es) Derivado de bencenosulfonamida
BR9908321A (pt) Composto
DE60014339D1 (de) Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
DK0664807T3 (da) Quinoxalindionderivater som EAA-antagonister
PE20030539A1 (es) Derivados de piperazina antagonistas de los receptores de somatostatina sst1
CA2388470A1 (en) Use of carbonylamino derivatives against cns disorders
ES2182509T3 (es) Derivados de n-ariloxietilamina para el tratamiento de la depresion.
PE20040788A1 (es) Derivados de indol con afinidad al receptor de androgeno
HUP9800889A1 (hu) Új naftil-piperazin-származékok
PT1140919E (pt) Novos derivados de ciclohexano 1,4-dissubstituido para o tratamento da depressao
AR009786A1 (es) Pirrolcarboxamidas fusionadas, una nueva clase de ligandos receptores cerebrales gaba

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application